[HTML][HTML] Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
C Rabasco, T Cavero, E Román, J Rojas-Rivera… - Kidney international, 2015 - Elsevier
C3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or
dominant deposits of C3 on immunofluorescence. To explore the effect of …
dominant deposits of C3 on immunofluorescence. To explore the effect of …
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
C Rabasco, T Cavero, E Román… - Kidney …, 2015 - kidney-international.org
C3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or
dominant deposits of C3 on immunofluorescence. To explore the effect of …
dominant deposits of C3 on immunofluorescence. To explore the effect of …
[引用][C] Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
C Rabasco, T Cavero, E Román, J Rojas-Rivera… - Kidney …, 2015 - cir.nii.ac.jp
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
C Rabasco, T Cavero, E Román… - Kidney …, 2015 - pubmed.ncbi.nlm.nih.gov
C3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or
dominant deposits of C3 on immunofluorescence. To explore the effect of …
dominant deposits of C3 on immunofluorescence. To explore the effect of …
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
C Rabasco, T Cavero, E Román, J Rojas-Rivera… - Kidney …, 2015 - europepmc.org
C3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or
dominant deposits of C3 on immunofluorescence. To explore the effect of …
dominant deposits of C3 on immunofluorescence. To explore the effect of …